Last reviewed · How we verify
Tartrazol Yellow (tartrazine)
Tartrazol Yellow (generic name: tartrazine) is a tartrazine drug. It is currently in unknown development.
Tartrazine works by binding to and altering the activity of certain proteins in the body.
Tartrazol Yellow, also known as E102, is a synthetic lemon yellow azo dye primarily used as a food coloring. It is also known by other names such as Tartrazine, C.I. 19140, FD&C Yellow 5, and Yellow 5 Lake.
At a glance
| Generic name | tartrazine |
|---|---|
| Drug class | tartrazine |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Think of it like a key fitting into a lock - tartrazine is like the key that changes the way proteins work, which can affect how our bodies respond to different stimuli. However, the exact way it does this is still not fully understood. It's a bit like a puzzle piece that fits into a larger puzzle, but we don't know what the whole picture looks like.
Approved indications
Common side effects
Key clinical trials
- Topical Tartrazine for Improved Skin Structure Visualization in Dermatology (EARLY_PHASE1)
- Curcumin Supplementation for the Improvement of Diabetes-related Outcomes (NA)
- Effect of Oral Curcumin Supplementation in Dry Age-related Macular Degeneration (AMD) Patients (EARLY_PHASE1)
- A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS) (PHASE3)
- A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients (PHASE4)
- A Safety, Efficacy and Tolerability Study of Sativex for the Treatment of Spasticity in Children Aged 8 to 18 Years (PHASE3)
- A Safety Study of Sativex Compared With Placebo (Both With Dose-intense Temozolomide) in Recurrent Glioblastoma Patients (PHASE1,PHASE2)
- Urinary Track Infection Prevention After Urogynecological Surgery (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tartrazol Yellow CI brief — competitive landscape report
- Tartrazol Yellow updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Tartrazol Yellow
What is Tartrazol Yellow?
How does Tartrazol Yellow work?
What is the generic name of Tartrazol Yellow?
What drug class is Tartrazol Yellow in?
What development phase is Tartrazol Yellow in?
Related
- Drug class: All tartrazine drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing